Viale G - Search Results

1

Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases.

Castellano I, Sapino A, Arisio R, Viale G, Bussolati G, Bandelloni R, Barresi G, Bersiga A, Bordi C, Botti G, Cosimi F, D'Amore E, Doglioni C, Marchetti A, Nappi O, Romeo F, Roncalli M, Russo R, Santinelli A, Spagnoli LG, Tanda F, Tricomi P, Trentini G, Zanconati F, Iurlaro M. Castellano I, et al. Among authors: viale g. Oncol Rep. 2008 May;19(5):1271-5. Oncol Rep. 2008. PMID: 18425387

2

A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.

Colombo N, Formelli F, Cantù MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, Decensi A. Colombo N, et al. Among authors: viale g. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1914-9. doi: 10.1158/1055-9965.EPI-06-0183. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035399 Clinical Trial.

3

HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17.

Torrisi R, Rotmensz N, Bagnardi V, Viale G, Curto BD, Dell'orto P, Veronesi P, Luini A, D'Alessandro C, Cardillo A, Goldhirsch A, Colleoni M. Torrisi R, et al. Among authors: viale g. Eur J Cancer. 2007 Nov;43(16):2339-44. doi: 10.1016/j.ejca.2007.07.033. Epub 2007 Sep 12. Eur J Cancer. 2007. PMID: 17855075

4

Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study.

Montemurro F, Redana S, Nolè F, Donadio M, Jacomuzzzi ME, Valabrega G, Viale G, Sapino A, Aglietta M. Montemurro F, et al. Among authors: viale g. BMC Cancer. 2008 Jul 24;8:209. doi: 10.1186/1471-2407-8-209. BMC Cancer. 2008. PMID: 18652678 Free PMC article.

5

Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib era.

Montemurro F, Redana S, Viale G, Sanna G, Donadio M, Valabrega G, del Curto B, Bottini A, Botti G, dei Tos AP, Jacomuzzi ME, Di Bonito M, Danese S, Clavarezza M, Kulka J, Di Palma S, Durando A, Sapino A, Aglietta M. Montemurro F, et al. Among authors: viale g. Clin Breast Cancer. 2008 Oct;8(5):436-42. doi: 10.3816/CBC.2008.n.053. Clin Breast Cancer. 2008. PMID: 18952558

6

Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer.

Curigliano G, Viale G, Bagnardi V, Fumagalli L, Locatelli M, Rotmensz N, Ghisini R, Colleoni M, Munzone E, Veronesi P, Zurrida S, Nolè F, Goldhirsch A. Curigliano G, et al. Among authors: viale g. J Clin Oncol. 2009 Dec 1;27(34):5693-9. doi: 10.1200/JCO.2009.22.0962. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884553

7

Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison.

Redana S, Donadio M, Nolè F, Jacomuzzi ME, Beano A, Martinello R, Sapino A, Viale G, Aglietta M, Montemurro F. Redana S, et al. Among authors: viale g. BMC Cancer. 2010 Feb 1;10:28. doi: 10.1186/1471-2407-10-28. BMC Cancer. 2010. PMID: 20122160 Free PMC article.

8

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers.

Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R, Durando A, Donadio M, Bussolati G, Coates AS, Viale G, Sapino A. Castellano I, et al. Among authors: viale g. Breast Cancer Res Treat. 2010 Dec;124(3):607-17. doi: 10.1007/s10549-010-0761-y. Epub 2010 Feb 3. Breast Cancer Res Treat. 2010. PMID: 20127405

9

Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients.

Montemurro F, Rossi V, Cossu Rocca M, Martinello R, Verri E, Redana S, Adamoli L, Valabrega G, Sapino A, Aglietta M, Viale G, Goldhirsch A, Nolè F. Montemurro F, et al. Among authors: viale g. Cancer. 2012 Jan 1;118(1):17-26. doi: 10.1002/cncr.26162. Epub 2011 May 19. Cancer. 2012. PMID: 21598238 Free article.

10

Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer.

Asioli S, Maletta F, Verdun di Cantogno L, Satolli MA, Schena M, Pecchioni C, Botta C, Chiusa L, Molinaro L, Conti L, Viale G, Ingravallo G, Maiorano E, Sapino A. Asioli S, et al. Among authors: viale g. Hum Pathol. 2012 Nov;43(11):2070-9. doi: 10.1016/j.humpath.2012.02.017. Epub 2012 Jun 1. Hum Pathol. 2012. PMID: 22658277 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

998 results

Search Page

Filters